These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22572593)

  • 1. Treatment of toxic epidermal necrolysis with the combination of infliximab and high-dose intravenous immunoglobulin.
    Gaitanis G; Spyridonos P; Patmanidis K; Koulouras V; Nakos G; Tzaphlidou M; Bassukas ID
    Dermatology; 2012; 224(2):134-9. PubMed ID: 22572593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
    Yang Y; Xu J; Li F; Zhu X
    Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases.
    Chen J; Wang B; Zeng Y; Xu H
    Eur J Dermatol; 2010; 20(6):743-7. PubMed ID: 20952352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
    Tan SK; Tay YK
    Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis and Stevens-Johnson/toxic epidermal necrolysis overlap syndrome. Review of 15 cases].
    Molgó M; Carreño N; Hoyos-Bachiloglu R; Andresen M; González S
    Rev Med Chil; 2009 Mar; 137(3):383-9. PubMed ID: 19621180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulins and plasmapheresis combined treatment in patients with severe toxic epidermal necrolysis: preliminary report.
    Lissia M; Figus A; Rubino C
    Br J Plast Surg; 2005 Jun; 58(4):504-10. PubMed ID: 15897036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic epidermal necrolysis: analysis of clinical course and SCORTEN-based comparison of mortality rate and treatment modalities in Korean patients.
    Kim KJ; Lee DP; Suh HS; Lee MW; Choi JH; Moon KC; Koh JK
    Acta Derm Venereol; 2005; 85(6):497-502. PubMed ID: 16396796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose intravenous immunoglobulin in the treatment of toxic epidermal necrolysis: a study of ocular benefits.
    Yip LW; Thong BY; Tan AW; Khin LW; Chng HH; Heng WJ
    Eye (Lond); 2005 Aug; 19(8):846-53. PubMed ID: 15389280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective, noncomparative open study from Kuwait of the role of intravenous immunoglobulin in the treatment of toxic epidermal necrolysis.
    Al-Mutairi N; Arun J; Osama NE; Amr Z; Mazen AS; Ibtesam el-A; Nazeha el-B
    Int J Dermatol; 2004 Nov; 43(11):847-51. PubMed ID: 15533072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical quantification of the inflammatory cell infiltrate and CD95R expression during treatment of drug-induced toxic epidermal necrolysis.
    Paquet P; Jacob E; Damas P; Pirson J; Piérard G
    Arch Dermatol Res; 2005 Dec; 297(6):266-73. PubMed ID: 16249890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic epidermal necrolysis successfully treated with infliximab.
    Zárate-Correa LC; Carrillo-Gómez DC; Ramírez-Escobar AF; Serrano-Reyes C
    J Investig Allergol Clin Immunol; 2013; 23(1):61-3. PubMed ID: 23653980
    [No Abstract]   [Full Text] [Related]  

  • 13. Skin immunoglobulin deposition following intravenous immunoglobulin therapy in toxic epidermal necrolysis.
    Paquet P; Kaveri S; Jacob E; Pirson J; Quatresooz P; Piérard GE
    Exp Dermatol; 2006 May; 15(5):381-6. PubMed ID: 16630079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical evaluation of toxic epidermal necrolysis treated with human intravenous immunoglobulin.
    Romanelli P; Schlam E; Green JB; Trent JT; Ricotti C; Elgart GW; Kirsner RS; Kerdel FA
    G Ital Dermatol Venereol; 2008 Aug; 143(4):229-33. PubMed ID: 18833079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre.
    Rajaratnam R; Mann C; Balasubramaniam P; Marsden JR; Taibjee SM; Shah F; Lim R; Papini R; Moiemen N; Lewis H
    Clin Exp Dermatol; 2010 Dec; 35(8):853-62. PubMed ID: 20456393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of N-acetylcysteine combined with infliximab on toxic epidermal necrolysis. A proof-of-concept study.
    Paquet P; Jennes S; Rousseau AF; Libon F; Delvenne P; Piérard GE
    Burns; 2014 Dec; 40(8):1707-12. PubMed ID: 24726294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of intravenous immunoglobulin in toxic epidermal necrolysis: a retrospective analysis of 64 patients managed in a specialized centre.
    Lee HY; Lim YL; Thirumoorthy T; Pang SM
    Br J Dermatol; 2013 Dec; 169(6):1304-9. PubMed ID: 24007192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In a patient with toxic epidermal necrolysis, does intravenous immunoglobulin improve survival compared with supportive care?
    Wootton CI; Patel AN; Williams HC
    Arch Dermatol; 2011 Dec; 147(12):1437-40. PubMed ID: 22184767
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxic epidermal necrolysis: review of pathogenesis and management.
    Downey A; Jackson C; Harun N; Cooper A
    J Am Acad Dermatol; 2012 Jun; 66(6):995-1003. PubMed ID: 22169256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stevens-Johnson syndrome and toxic epidermal necrolysis: efficacy of intravenous immunoglobulin and a review of treatment options.
    Teo L; Tay YK; Liu TT; Kwok C
    Singapore Med J; 2009 Jan; 50(1):29-33. PubMed ID: 19224081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.